Stock Ideas
Sunesis Pharmaceuticals (SNSS) Soars on Merger Deal with Viracta Therapeutics
The merger agreement between both Sunesis and Viracta will focus on the oncology pipeline. The combined company will be listed on Nasdaq and is anticipated to
